Drug incompatibility chemistry

American Journal of Health-System Pharmacy

Volumn 66, Issue 4, 2009, Pages 348-357

  Newton, David W ^a  

^a SHENANDOAH UNIVERSITY   (United States)

Author keywords

Concentration; Electrolytes; Hydrogen ion concentration; Incompatibilities; Injections; Polarity; Precipitation; Salts; Solubility; Solutions; Stability

Indexed keywords

CALCIUM PHOSPHATE; ELECTROLYTE; ION; ORGANIC COMPOUND; SODIUM CHLORIDE; FUROSEMIDE; PHENYLEPHRINE;

ACID BASE BALANCE; AQUEOUS SOLUTION; BIOEQUIVALENCE; CHEMICAL INTERACTION; CONCENTRATION (PARAMETERS); DILUTION; DRUG FORMULATION; DRUG INCOMPATIBILITY; DRUG LABELING; DRUG MARKETING; DRUG SOLUTION; HEALTH HAZARD; INJECTION; IONIZATION; PH; PRECIPITATION; PRIORITY JOURNAL; REVIEW; CHEMISTRY; MEDICAL LITERATURE; SOLUBILITY;

CHEMISTRY, PHARMACEUTICAL; DRUG INCOMPATIBILITY; ELECTROLYTES; FUROSEMIDE; PHARMACOPOEIAS AS TOPIC; PHENYLEPHRINE; PRECIPITATION; SOLUBILITY;

EID: 59849127039     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp080059     Document Type: Review

References (62)

1. Faria CE, Fiumara K, Patel N et al. Visual compatibility of furosemide with phenylephrine and vasopressin. Am J Health- Syst Pharm. 2006; 63:906-8. Letter.
2. Allen LV, Levison RS, Phisutsinthop D. Compatibility of various admixtures with secondary additives at Y-injection sites of intravenous administration sets. Am J Hosp Pharm. 1977; 34:939-43.
3. Roche VF. Improving pharmacy students' understanding and long-term retention of acid-base chemistry. Am J Pharm Educ. 2007;71:Article 122.
4. Arny HV, Fischelis RP. Principles of pharmacy. 4th ed. Philadelphia, PA: W. B. Saunders; 1937:25.
5. Skau K. Pharmacy is a science-based profession. Am J Pharm Educ. 2006; 71: Article 11.
6. Newton DW. Science-based pharmacy education. Am J Pharm Educ. 2007; 71:Article 38.
7. North GT, Anderson WD. Interpreting, rather than reciting, the literature on drug compatibilities. Am J Hosp Pharm. 1995; 52:1400,1404.
8. Miller KW. Coordinating and optimizing educational efforts between basic science and clinical faculty: pharmaceutics. Am J Pharm Educ. 1975; 39:576-8.
9. Burkiewicz JS. Incompatibility of ceftriaxone sodium with lactated Ringer's injection. Am J Health-Syst Pharm. 1999; 56:384. Letter.
10. Murray L. Physicians' desk reference. 61st ed. Montvale, NJ: Thomson PDR; 2007:1026,1030.
11. Mendenhall A, Hoyt DB. Incompatibility of ketorolac tromethamine with haloperidol lactate and thiethylperazine maleate. Am J Hosp Pharm. 1994; 51:2964.
12. Newton DW. Physicochemical determinants of incompatibility and instability in injectable drug solutions and admixtures. Am J Hosp Pharm. 1978; 35:1213-22.
13. Newton DW. Introduction: physico-chemical determinants of incompatibility and instability of drugs for injection and infusion. In: Trissel LA. Handbook on injectable drugs. 3rd ed. Bethesda, MD: American Society of Hospital Pharmacists; 1983:xi-xxi.
14. Newton DW, Narducci WA. Extemporaneous formulations. In: King RE, ed. Dispensing of medication. 9th ed. Easton, PA: Mack; 1984:281-5.
15. Turco SJ. Intravenous admixtures. In: Troy DB, ed. Remington: the science and practice of pharmacy. 21st ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005:847.
16. O'Donnell PB, Bokser AD. Stability of pharmaceutical products. In: Troy DB, ed. Remington: the science and practice of pharmacy. 21st ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005:1025- 36.
17. Driscoll DF, Joy J, Silvestri AP et al. Calcium (Ca) and phosphate (P) compatibility in low osmolality parenteral nutrition (PN) mixtures. Clin Nutr. 2005; 24:695.
18. Trissel LA. Handbook on injectable drugs. 14th ed. Bethesda, MD: American Society of Health-System Pharmacists; 2007.
19. Lyman RA, Urdang G. In: Lyman RA, ed. Pharmaceutical compounding and dispensing. Philadelphia, PA: J. B. Lippincott; 1949: v.
20. Henderson LJ. A diagrammatic representation of equilibria between acids and bases in solution. J Am Chem Soc. 1908; 30:954-60.
21. Hasselbalch KA. The calculation of the hydrogen number of the blood from the free and bound carbon dioxide of the same and the binding of oxygen by the blood as a function of the hydrogen number. Biochem Z. 1916; 78:112-44.
22. Lemke TL, Williams DA, Roche VF et al. Foye's principles of medicinal chemistry. 6th ed. Baltimore, MD: Lippincott Williams & Wilkins; 2008:28-38,85, 175.
23. Martin AN. Physical pharmacy. 4th ed. Philadelphia, PA: Lea & Febiger; 1993:22- 3,130-2,144-6,149,169-70,179,214-5,232- 5,396-7.
24. Newton DW, Kluza RB. Prediction of phenytoin solubility in intravenous admixtures: physicochemical theory. Am J Hosp Pharm. 1980; 37:1647-51.
25. a values of medicinal compounds in pharmacy practice. Druglntell Clin Pharm. 1978; 12:546-54.
26. Allen LV Jr, Popovich NG, Ansel HC. Ansel's pharmaceutical dosage forms and delivery systems. 8th ed. Baltimore, MD: Lippincott Williams & Wilkins; 2005:112, 145-6,152,338-41.
27. Block JH, Beale JM Jr, eds. Wilson and Gisvold's textbook of organic medicinal and pharmaceutical chemistry. 11th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2004:9-16,31,951.
28. Lemke TL. Review of organic functional groups. 4th ed. Baltimore, MD: Lippincott Williams & Wilkins; 2003:4,46-7,123, 132-40.
29. Gennaro AR. Organic pharmaceutical chemistry. In: Troy DB, ed. Remington: the science and practice of pharmacy. 21st ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005:391-400.
30. Lien EJ. Molecular structure, properties, and states of matter. In: Troy DB, ed. Remington: the science and practice of pharmacy. 21st ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005: 172-3.
31. Gupta PK. Solutions and phase equilibria. In: Troy DB, ed. Remington: the science and practice of pharmacy. 21st ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005:214-5,220-4.
32. Berge SM, Bighley LD, Monkhouse DL. Pharmaceutical salts. J Pharm Sci. 1977; 66:1-19.
33. The United States pharmacopeia, 30th rev, and The national formulary, 26th ed. Rockville, MD: United States Pharmacopeial Convention; 2007:9,886-94.
34. Devlin TM, ed. Textbook of biochemistry with clinical correlations. 6th ed. Hoboken, NJ: Wiley-Liss; 2006:113-5.
35. Robinson WR, Odom JD, Holtzclaw HF Jr. General chemistry. 10th ed. Boston, MA: Houghton Mifflin; 1997:375-6, 419-20, 448, 590-604, 622.
36. Kotz JC, Treichel P Jr. Chemistry and chemical reactivity. 4th ed. Orlando, FL: Saunders; 1999:597.
37. Lagowski JJ, ed. Chemistry: foundations and applications. Vol. 1. New York: Macmillan Reference USA; 2004:133,139.
38. Karplus M, Porter RN. Atoms and molecules. Menlo Park, CA: W. A. Benjamin; 1970:269.
39. Schmid GH. The chemical basis of life. Boston: Little, Brown; 1982:110-1,642-7, 664-5,718-22.
40. Morrison RT, Boyd RN. Organic chemistry. Boston, MA: Allyn & Bacon; 1959:71-2.
41. O'Neil MJ Sr, ed. The Merck index. 13th ed. Whitehouse Station, NJ: Merck & Co.; 2001:183,284-5,324,335,475,765,833, 1547-8.
42. Shuster J. Psychopharmacologic agents. In: Troy DB, ed. Remington: the science and practice of pharmacy. 21st ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005:1520.
43. Ionic solutions and electrolytic equlibria. In: Troy DB, ed. Remington: the science and practice of pharmacy. 21st ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005:235-45.
44. Theesen KA, Wilson JE, Newton DW et al. Compatibility of lithium citrate syrup with 10 neuroleptic solutions. Am J Hosp Pharm. 1981;38:1750-3.
45. Newton DW, Driscoll DF. Calcium and phosphates compatibility: revisited again. Am J Health-Syst Pharm. 2008; 65:73-80.
46. Yalkowsky SH, Valvani SC. Precipitation of solubilized drugs due to injection or dilution. Drug Intell Clin Pharm. 1977; 11:417-9.
47. Newton DW, Driscoll DF, Goudreau JL et al. Solubility characteristics of diazepam in aqueous admixture solutions: theory and practice. Am J Hosp Pharm. 1981; 38:179-82.
48. Bowman BJ, Ofner CM III, Schott H. Colloidal dispersions. In: Troy DB, ed. Remington: the science and practice of pharmacy. 21st ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005: 311-3.
49. U.S. Food and Drug Administration. Center for Drug Evaluation and Research. Ceftriaxone (marketed as Rocephin) information, www.fda.gov/cder/drug/ infopage/ceftriaxone/default.htm (accessed 2008 Jan 29).
50. Allen LV Jr, Popovich NG, Ansel HC. Ansel's pharmaceutical dosage forms and delivery systems. 8th ed. Baltimore, MD: Lippincott Williams & Wilkins; 2005:148,167.
51. March J. Advanced organic chemistry: reactions, mechanisms, and structure. 2nd ed. New York: McGraw-Hill; 1977:238-43.
52. Hine J. Structural effects on equilibria in organic chemistry. New York: Wiley; 1975:1-3,29-53.
53. Shargel L, Wu-Pong S, Yu AC. Applied biopharmaceutics & pharmacokinetics. 5th ed. New York: McGraw-Hill; 2005:386.
54. Buxton ILO. Pharmacokinetics and pharmacodynamics. In: Brunton LL, ed. Goodman & Gilman's the pharmacological basis of therapeutics. 11th ed. New York: McGraw-Hill; 2006:5.
55. Newton DW, Narducci WA, Leet WA et al. Lorazepam solubility in and sorption from intravenous admixture solutions. Am J Hosp Pharm. 1983; 40:424-7.
56. Kozma MT, Newton DW. Nursing guidelines for in-syringe mixtures. Superv Nurse. 1975; 6:26-7,31-2.
57. Drug incompatibility delayed execution. PNN Pharmacotherapy Line. 1994; 1:1.
58. Higuchi T. Solubility. In: Lyman RA, ed. Pharmaceutical compounding and dispensing. Philadelphia, PA: J. B. Lippincott; 1949:161-7,174-5.
59. Trissel LA. Handbook on injectable drugs. 14th ed. Bethesda, MD: American Society of Health-System Pharmacists; 2007:757.
60. The United States pharmacopeia, 30th rev, and The national formulary, 26th ed. Rockville, MD: United States Pharmacopeial Convention; 2007:1316,1927-8, 2137,2239,2986,2999,3245.
61. Newton DW. Phenytoin injections: from compounding to Cerebyx. Int J Pharm Compound. 2002; 6:410-3.
62. Trissel LA. Handbook on injectable drugs. 14th ed. Bethesda, MD: American Society of Health-System Pharmacists; 2007:242-58,1340-7,1384-90,1501-4.